Medication Use and Pregnancy > Research

NCBDDD Publications

Articles, Chapters, and MMWRs

The following are articles and publications that include CDC authors and highlight some of CDC’s work in the area of medication use during pregnancy.

Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Medication Use During Pregnancy and Lactation: An Urgent Call for Public Health Action. J Women’s Health. 2005 Mar;14(2):103-108. Abstract

Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193(3 Pt 1):771-7. Abstract

Honein MA, Moore CA, Erickson JD. Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example. Drug Saf. 2004;27(14):1069-80. Abstract

Evaluation of an association between loratadine and hypospadias--United States, 1997-2001. MMWR. 2004;53(10):219-21.Full text

Abe K, Honein MA, Moore CA. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. Birth Defects Res Part A Clin Mol Teratol. 2003;67(11):911-8. Abstract

Daniel KL, Honein MA, Moore CA. Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies.
Pediatrics. 2003 May;111(5 Part 2):1167-70. Abstract

Williams J, Lyss S, and Cragan J. Your pregnant or lactating patient has been exposed to anthrax: now what? Contemporary OB/GYN. 2003:84-98.  No Abstract Available

Honein MA, Moore CA, Lyon Daniel K, Erickson JD. Problems with informing women adequately about teratogen risk: some barriers to preventing exposures to known teratogens. Teratology. 2002 May;65(5):202-4.  No Abstract Available

Olney RS, Moore CA. Translating research findings into public health action and policy. In: Wyszynski DF, editor. Cleft lip and palate. From origin to treatment. New York: Oxford University Press;2002:488-94.  No Abstract Available

Honein MA, Paulozzi LJ, Erickson JD Continued occurrence of Accutane®-exposed pregnancies Teratology. 2001 Sep;64(3):142-7 Abstract

Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD.  The National Birth Defects Prevention Study. Public Health Rep. 2001;116 Suppl 1:32-40. Abstract

Honein MA, Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of pregnancy drug registries. Teratology. 1999;60(6):356-64. Abstract

Accutane®-exposed pregnancies--California, 1999. MMWR. 2000;49(2):28-31.  Full text

Isotretinoin--A newly recognized human teratogen. MMWR. 1984;33(13):171-3. Full text

Guidelines and Recommendations

The following guidelines and recommendations were drafted by scientists from CDC and other agencies.

Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment--Update 2004   Full Text 
These NIH recommendations, updated during 2004, provide guidance on pharmacological treatment for pregnant women with asthma.

Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis Full Text
These recommendations, published in the Morbidity and Mortality Weekly Report, are used to provide guidance for physicians in choosing the best antibiotic for their patient.

Smallpox Vaccination Information for Women Who are Pregnant or Breastfeeding   Full Text

U.S. Public Health Service Task Force Recommendations for Use--of Antiretroviral Drugs in Pregnant HIV-1--Infected Women for Maternal Health and Interventions To Reduce Perinatal HIV-1 Transmission in the United States  Full Text

Date: October 29, 2004
Content source: National Center on Birth Defects and Developmental Disabilities